An investment firm managing various funds including the Midlands Engine Investment Fund and EIS funds.
The funding round was secured from the MEIF Proof of Concept and Early Stage Fund alongside Mercia and angel investors to support global growth.
"PHARMASEAL aims to give customers increased control over their clinical trials and product development. This second round of investment demonstrates the confidence that investors have in our product and will enable us to scale up our commercial operations."
The Birmingham property platform raised £250k from Mercia and private investors to fund commercial rollout and hiring.
"From our work in the property sector and experience as landlords, we recognised that there was a gap in the market for a platform that could bring together all the different aspects of property investment and management. We are looking forward to the launch of Rent Chief and working with our investors as we continue to develop and enhance the product."
The financing values the synthetic biology business at £30.5m post-money.
"This significant investment round will enable Oxford Genetics to further secure its market-leading position in the expanding fields of CRISPR, gene therapy and antibody engineering. Through our continued investment in automation and optimising our commercialisation strategy, we aim to maximise shareholder value and exceed our ambitious growth targets. Throughout our journey, Mercia’s investment model has been pivotal to Oxford Genetics’ current success. The ability to leverage capital and continued support from Mercia via seed stage through to later investment rounds has enabled us to attract excellent syndicate investors onto our share register. We are excited to welcome Canaccord Genuity onto our share register alongside Invesco Asset Management and look forward to working with all of our investors to grow the business over the coming years."
The seed round was led by Mercia Fund Management with backing from angel investors.
"Mercia is the perfect partner for us, as their 'Complete Capital Solution' will be able to meet our needs as a personalised healthcare technology start-up. We need an investor that understands our journey ahead and can help us plan for future growth."
Mercia Fund Management backed the academic research platform in its first external funding round.
"This investment marks the next chapter in our business’s history, and heralds not only our expansion, but also the development of new and current core services for our university and company clients. We’re looking to maintain our traction, and are excited to excel expectations as we take our company overseas with our new partners at MFM."
